Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Abstract Background The standard treatment for osteoporosis was controversial. Denosumab and bisphosphonates were two most common drugs. The purpose of this study was to compare the efficacy and safety of denosumab with bisphosphonates to treat osteoporosis. Methods Published literatures, only inclu...
Main Authors: | Jiaqi Wu, Qingsheng Zhang, Guanghui Yan, Xianhui Jin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-08-01
|
Series: | Journal of Orthopaedic Surgery and Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13018-018-0865-3 |
Similar Items
-
The efficacy and safety of denosumab in postmenopausal women with osteoporosis previously treated with bisphosphonates: A review
by: Yilin Zhu, et al.
Published: (2020-05-01) -
The Bisphosphonates versus Denosumab Efficiency in Postmenopausal Osteoporosis Treatment
by: Lorena Ciumărnean, et al.
Published: (2017-05-01) -
Long-term treatment options for postmenopausal osteoporosis: results of recent clinical studies of Denosumab
by: Zhanna E. Belaya, et al.
Published: (2018-04-01) -
Update on Denosumab Treatment in Postmenopausal Women with Osteoporosis
by: Yong-Ki Min
Published: (2015-03-01) -
Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates
by: Tetsuya Kaneko, et al.
Published: (2019-10-01)